Affinity Asset Advisors

Latest statistics and disclosures from Affinity Asset Advisors's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Affinity Asset Advisors

Companies in the Affinity Asset Advisors portfolio as of the September 2021 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Spdr Ser Tr S&p Biotech Put Option (XBI) 22.2 $88M +250% 700k 125.71
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) 10.8 $43M NEW 100k 429.14
Bridgebio Pharma (BBIO) 7.7 $31M +18% 654k 46.87
Vincerx Pharma Com New (VINC) 4.1 $16M +19% 1.0M 16.17
Morphic Hldg (MORF) 3.9 $15M +9% 271k 56.64
Inari Medical Ord (NARI) 2.8 $11M +58% 135k 81.10
Kura Oncology (KURA) 2.5 $9.9M +24% 530k 18.73
Springworks Therapeutics (SWTX) 2.0 $8.0M +404% 126k 63.44
Cerevel Therapeutics Hldng I (CERE) 1.9 $7.7M +29% 260k 29.50
Ocular Therapeutix (OCUL) 1.9 $7.5M +200% 750k 10.00
Travere Therapeutics Note 2.500% 9/1 (Principal) 1.8 $7.1M 7.0M 1.01
Arya Sciences Acquisitn Corp Class A Ord Shs 1.8 $6.9M NEW 703k 9.88
Aclaris Therapeutics (ACRS) 1.6 $6.3M +27% 350k 18.00
Acceleron Pharma (XLRN) 1.5 $6.1M -35% 35k 172.11

Setup an alert

Affinity Asset Advisors will file the next quarterly 13-HR in about 3 months. Would you like to be notified?

Arya Sciences Acqu Corp Iv Cl A (ARYD) 1.5 $6.0M -14% 600k 10.06
Nautilus Biotechnology (NAUT) 1.5 $6.0M +8% 975k 6.14
Ascendis Pharma A/s Sponsored Adr (ASND) 1.4 $5.7M +79% 36k 159.40
Zentalis Pharmaceuticals (ZNTL) 1.3 $5.2M -45% 78k 66.65
Mirati Therapeutics (MRTX) 1.2 $4.9M NEW 28k 176.91
Travere Therapeutics (TVTX) 1.2 $4.9M NEW 200k 24.25
Cassava Sciences Put Option (SAVA) 1.2 $4.7M NEW 75k 62.08
Curis Com New (CRIS) 1.1 $4.5M -11% 575k 7.83
Cytokinetics Com New (CYTK) 1.1 $4.5M +78% 125k 35.74
Establishment Labs Holdings Ord (ESTA) 1.1 $4.3M +200% 60k 71.58
Editas Medicine Put Option (EDIT) 1.0 $4.1M NEW 100k 41.08
Iovance Biotherapeutics (IOVA) 0.9 $3.7M +50% 150k 24.66
Nanostring Technologies (NSTG) 0.9 $3.6M +400% 75k 48.01
Trillium Therapeutics Com New (TRIL) 0.9 $3.5M NEW 200k 17.56
Centessa Pharmaceuticals Sponsored Ads (CNTA) 0.9 $3.4M +203% 203k 16.70
Bellus Health Com New (BLU) 0.8 $3.3M +77% 532k 6.14
Rafael Hldgs Com Cl B Put Option (RFL) 0.8 $3.1M NEW 101k 30.73
Procept Biorobotics Corp 0.8 $3.0M NEW 79k 38.15
Health Sciences Acq Corp 2 Ord Shs (HSAQ) 0.7 $3.0M 300k 9.89
Environmental Impact Acqu Com Cl A (ENVI) 0.7 $3.0M NEW 300k 9.89
Medicus Sciences Acquisition Cl A Shs (MSAC) 0.7 $2.9M 300k 9.75
Rocket Pharmaceuticals (RCKT) 0.6 $2.4M -33% 80k 29.89
Celldex Therapeutics Com New (CLDX) 0.5 $2.2M -19% 40k 53.99
Cyclacel Pharmaceuticals (CYCC) 0.5 $2.1M +5% 400k 5.27
Gossamer Bio Note 5.000% 6/0 (Principal) 0.5 $2.1M 2.0M 1.04
Intellia Therapeutics (NTLA) 0.5 $2.0M +50% 15k 134.13
Harpoon Therapeutics (HARP) 0.5 $2.0M +400% 250k 7.90
Global Blood Therapeutics In (GBT) 0.5 $1.9M +275% 75k 25.48
United Therapeutics Corporation (UTHR) 0.5 $1.8M NEW 10k 184.60
Acutus Medical (AFIB) 0.4 $1.8M +150% 200k 8.84
Aldeyra Therapeutics (ALDX) 0.4 $1.7M 198k 8.78
Seer Com Cl A Call Option (SEER) 0.4 $1.7M NEW 50k 34.54
Horizon Therapeutics Pub L SHS (HZNP) 0.4 $1.6M -40% 15k 109.53
Mereo Biopharma Group Ads (MREO) 0.4 $1.6M 650k 2.42
Butterfly Network Com Cl A (BFLY) 0.4 $1.6M +50% 150k 10.44
Lifesci Acquisition Ii Corp (LSAQ) 0.4 $1.5M 150k 9.80
Schrodinger (SDGR) 0.3 $1.4M 25k 54.68
Vaxcyte (PCVX) 0.3 $1.3M 50k 25.38
Zymeworks (ZYME) 0.3 $1.1M +29% 39k 29.04
Berkeley Lts (BLI) 0.3 $1.1M NEW 55k 19.56
Amicus Therapeutics (FOLD) 0.3 $1.1M NEW 111k 9.55
Galapagos Nv Spon Adr (GLPG) 0.3 $1.1M 20k 52.60
Biohaven Pharmaceutical Holding (BHVN) 0.3 $1.0M NEW 7.5k 138.93
Renovacor 0.3 $1.0M NEW 115k 9.05
Chinook Therapeutics (KDNY) 0.2 $949k -62% 74k 12.77
Pulmonx Corp (LUNG) 0.2 $900k -58% 25k 36.00
Immatics *w Exp 07/01/2020 (IMTXW) 0.2 $800k 190k 4.21
Achilles Therapeutics Sponsored Ads (ACHL) 0.2 $779k +25% 100k 7.79
Innate Pharma S A Sponsored Ads (IPHA) 0.2 $771k NEW 125k 6.17
Xenon Pharmaceuticals (XENE) 0.2 $764k NEW 50k 15.28
Tango Therapeutics 0.2 $647k NEW 50k 12.94
Cytomx Therapeutics (CTMX) 0.2 $636k +66% 125k 5.09
The Beauty Health Company *w Exp 05/04/2026 (SKINW) 0.1 $498k -23% 34k 14.48
Keros Therapeutics (KROS) 0.1 $495k NEW 13k 39.60
Aslan Pharmaceuticals Ads (ASLN) 0.1 $445k NEW 250k 1.78
Immunovant Call Option (IMVT) 0.1 $261k 30k 8.70
Corvus Pharmaceuticals (CRVS) 0.1 $242k NEW 50k 4.84
Renovacor *w Exp 99/99/999 0.0 $60k NEW 75k 0.80
Medicus Sciences Acquisition *w Exp 02/12/2026 (MSACW) 0.0 $24k 33k 0.72

Past Filings by Affinity Asset Advisors

SEC 13F filings are viewable for Affinity Asset Advisors going back to 2020